REG.AX ASX
Regis Healthcare Limited
1W: -0.7%
1M: +5.2%
3M: -32.6%
YTD: -32.6%
1Y: -42.2%
3Y: +92.6%
5Y: +136.9%
A$4.40 ($3.06)
-0.03 (-0.68%)
Weekly Expected Move ±4.7%
A$4
A$4
A$4
A$5
A$5
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$336M
+9.8% ▲
5Y CAGR: +26.2%
Capital Expenditures
$142M
-64.2% ▼
5Y CAGR: +52.4%
Free Cash Flow
$194M
-11.6% ▼
5Y CAGR: +17.2%
Dividends Paid
$52M
-16.6% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$19M
-114.7% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$39M | -$28M | -$21M | $0 | $56M |
| Depreciation & Amort. | $103M | $126M | $128M | $0 | $56M |
| Stock-Based Comp. | $354K | $836K | $2M | $0 | $0 |
| Change in Working Capital | $71M | $34M | $292M | $271M | $491M |
| Other Non-Cash Items | -$3M | -$8M | -$148M | $35M | -$266M |
| Operating Cash Flow | $115M | $105M | $252M | $306M | $336M |
| — Investing Activities — | |||||
| Capital Expenditures | -$47M | -$51M | -$66M | -$86M | -$142M |
| Acquisitions (Net) | $26K | $7M | -$74M | -$45M | -$158M |
| Investment Purchases | -$1M | -$2M | -$1M | -$2M | -$1M |
| Investment Sales | $1M | $53M | $1M | $0 | $0 |
| Other Investing | -$1M | $0 | $3M | $111K | $0 |
| Investing Cash Flow | -$49M | $7M | -$137M | -$133M | -$301M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$36M | -$29M | -$70M | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$25M | -$13M | -$41M | -$44M | -$52M |
| Other Financing | -$1M | -$1M | -$1M | -$1M | -$2M |
| Financing Cash Flow | -$62M | -$43M | -$112M | -$46M | -$54M |
| Net Change in Cash | $262K | $57M | $4M | $128M | -$19M |
| Cash End of Period | $4M | $61M | $65M | $192M | $174M |
| Free Cash Flow | $68M | $54M | $187M | $220M | $194M |